Clinical Trial Update: Studying Biomarkers in Samples From Patients With Recurrent or Metastatic Head and Neck Cancer Treated on E1302 Trial

View source ↗

Summary

An update on the ECOG-ACRIN E1302 trial reports biomarker analyses using samples from patients with recurrent or metastatic head and neck cancer. The trial stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Snippet

Sponsor: Eastern Cooperative Oncology Group | Conditions: Head and Neck Cancer | Status: COMPLETED